tradingkey.logo
tradingkey.logo
Search

Transgene SA Says Myvac Platform To Initiate Phase 1 Trial In Second Indication In 2026

ReutersMar 24, 2026 5:25 PM

- Transgene SA TRNG.PA:

  • TRANSGENE SA - MYVAC PLATFORM TO INITIATE PHASE 1 TRIAL IN SECOND INDICATION IN 2026

  • TRANSGENE SA - 3-YEAR DISEASE-FREE SURVIVAL FOLLOW-UP FOR HNSCC EXPECTED IN Q2/Q3 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI